Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | S100A12 |
| Upstream (Parents) |
|---|
| (<<) LOC442271 → S100A12 |
| (<<) SELL → S100A12 |
| (<<) HBA2///HBA1 → S100A12 |
| (<<) VNN2 → S100A12 |
| (<<) FCN1 → S100A12 |
| (<<) FCGR3B → S100A12 |
| (<<) S100A9 → S100A12 |
| Downstream (Children) |
|---|
| S100A12 → TNFRSF10C (>>) |
| S100A12 → HBB (>>) |
| S100A12 → S100A8 (>>) |
| S100A12 → HBA2///HBA1 (>>) |
| S100A12 → LOC642103///MGAM (>>) |
| S100A12 → S100A5 (>>) |
| S100A12 → HBD (>>) |
| S100A12 → RHO (>>) |
| S100A12 → POU3F3 (>>) |
| S100A12 → KIR2DL4 (>>) |
| S100A12 → IGF2AS (>>) |
| S100A12 → GPR173 (>>) |
| S100A12 → BSN (>>) |
| S100A12 → OR3A3 (>>) |
| S100A12 → ACSBG1 (>>) |
| S100A12 → OR10H3 (>>) |
| S100A12 → MYBPH (>>) |
| S100A12 → KRT38 (>>) |
| S100A12 → TLX2 (>>) |
| S100A12 → PROP1 (>>) |
| S100A12 → THOC5 (>>) |
| S100A12 → RUNX2 (>>) |
| S100A12 → AIPL1 (>>) |
